ProCE Banner Activity

Overview of CLL Diagnosis, Evaluation, and Targeted Agents

Slideset Download
Download these slides from our ASH 2019 live satellite symposium on CLL to review the current state of CLL diagnosis and evaluation as well as targeted agents being used to treat CLL.

Released: December 05, 2019

Expiration: December 03, 2020

No longer available for credit.

Share

Faculty

Thomas J. Kipps

Thomas J. Kipps, MD

Evelyn and Edwin Tasch Chair in Cancer Research
Distinguished Professor and Deputy Director,
Research Operations
UCSD, Moores Cancer Center
University of California, San Diego
La Jolla, California

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene Ltd

Janssen Biotech Pharmacyclics

Pharmacyclics an AbbVie Company

Faculty Disclosure

Primary Author

Thomas J. Kipps, MD

Evelyn and Edwin Tasch Chair in Cancer Research
Distinguished Professor and Deputy Director,
Research Operations
UCSD, Moores Cancer Center
University of California, San Diego
La Jolla, California

Thomas J. Kipps, MD, PhD, has disclosed that he has received consulting fees from AbbVie, AstraZeneca, Genentech, Janssen, Oncternal, Pharmacyclics, and Velos Bio; funds for research support from AbbVie, AstraZeneca, Genentech, Juno, Oncternal, Pharmacyclics, and Velos Bio; and ownership interest from Oncternal and Velos Bio.